- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Eagle effect.
Displaying page 1 of 1.
EudraCT Number: 2013-003826-10 | Sponsor Protocol Number: EAGLE | Start Date*: 2014-01-24 |
Sponsor Name:IRCCS- Mario Negri Institute | ||
Full Title: EVALUATING THE MORPHOFUNCTIONAL EFFECTS OF ECULIZUMAB THERAPY IN PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: A PILOT, SINGLE ARM STUDY IN TEN PATIENTS WITH PERSISTENT HEAVY PROTEINURIA | ||
Medical condition: Membranoproliferative glomerulonephritis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018437-21 | Sponsor Protocol Number: LANTU_C_03680 | Start Date*: 2010-06-07 | |||||||||||
Sponsor Name:SANOFI AVENTIS GROUPE | |||||||||||||
Full Title: A 24-week, multicenter, international, randomized (1:1), parallel-group, open-label, comparative study of insulin glargine versus liraglutide in insulin-naïve patients with Type 2 diabetes treated ... | |||||||||||||
Medical condition: Type 2 diabetes not adequately controlled | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) IE (Completed) ES (Completed) SE (Completed) AT (Completed) FI (Completed) FR (Completed) NL (Completed) GR (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003836-77 | Sponsor Protocol Number: OCTO-003 | Start Date*: 2008-12-09 |
Sponsor Name:University of Oxford | ||
Full Title: AspECT - A phase III, randomised study of aspirin and esomeprazole chemoprevention in Barrett's metaplasia & oesophagitis. | ||
Medical condition: Barrett's Metaplasia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021424-94 | Sponsor Protocol Number: TMC-ORI-10-01 | Start Date*: 2012-03-16 | |||||||||||||||||||||||||||||||
Sponsor Name:The Medicines Company | |||||||||||||||||||||||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin... | |||||||||||||||||||||||||||||||||
Medical condition: Treatment of Patients with acute bacterial skin and skin structure infections | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) PL (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021720-10 | Sponsor Protocol Number: TMC-ORI-10-02 | Start Date*: 2012-03-16 | |||||||||||||||||||||||||||||||
Sponsor Name:The Medicines Company | |||||||||||||||||||||||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin... | |||||||||||||||||||||||||||||||||
Medical condition: Treatment of Patients with acute bacterial skin and skin structure infections | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
